GLP-1s, compounded peptides, and metabolic protocols demand serious physician oversight. We deliver the medical leadership, sourcing review, and compliance to scale your weight loss program safely.

Prescribing semaglutide and tirzepatide isn't a wellness trend — it's clinical practice with real risks. Without physician oversight, your weight loss program is a liability waiting to happen.
Our medical directors specialize in the modalities driving weight loss today — branded and compounded GLP-1s, lipotropics, lab-based metabolic care, and telehealth-first models. We bring the protocols, sourcing standards, and compliance framework that let you launch and scale defensibly.
From in-clinic injections to nationwide telehealth, our directors are fluent in the weight loss protocols your patients are asking for.
Semaglutide and tirzepatide protocols — branded and compounded — with titration, side-effect management, and discontinuation plans.
503A/503B sourcing reviewed and documented to align with state board guidance and the evolving FDA landscape.
Baseline and follow-up labs, A1C, lipid, and thyroid monitoring tied directly into prescribing protocols.
MIC, lipotropic, and B12 injection protocols layered into your weight loss programs with proper consent and oversight.
Defensible programs that combine pharmacotherapy with nutrition, behavior, and follow-up to drive real outcomes.
Asynchronous and synchronous workflows tuned to each state's rules for GLP-1 prescribing at scale.
Compliance, protocols, training, and strategy — the full operating system for a modern weight loss clinic.
GLP-1 rules vary by state and are changing fast. We keep your sourcing, prescribing, and marketing inside the lines.
Intake, lab panels, consent, dosing, titration, plateau, and discontinuation protocols designed for safety and outcomes.
NPs, RNs, and front-desk teams trained on contraindications, side effects, escalation, and patient communication.
We help you price, package, and scale your weight loss programs without crossing scope-of-practice lines.
Chart reviews, complex case consults, and quality audits that keep your program defensible and your outcomes high.
Corporate Practice of Medicine compliance with the MSO-PC framework that protects non-physician owners.
FDA scrutiny of compounded GLP-1s, state board enforcement actions, and shifting telehealth rules are reshaping the weight loss industry. Our team monitors the landscape so your sourcing, prescribing, and marketing stay defensible.
Compounding pharmacy vetting and documentation aligned with state board and FDA expectations.
Required baseline and follow-up labs built into every GLP-1 program — not bolted on after the fact.
Asynchronous and synchronous protocols tuned to each state's rules for weight loss prescribing.
A physician who actually understands GLP-1s, compounded sourcing, and metabolic care — not a signature on a form.
Active, unencumbered physicians with experience in obesity medicine, endocrinology, or internal medicine.
Familiar with semaglutide and tirzepatide protocols, compounded sourcing, and the FDA and state board landscape.
Licensed across the states your clinic or telehealth program serves — no oversight gaps.
A real clinical partner available for protocol updates, case reviews, and emergencies.
From your first GLP-1 patient to a multi-state telehealth program, we pair you with physicians who specialize in obesity and metabolic medicine — backed by protocols, legal structure, and ongoing oversight.
Find Your Medical Director